Treatment outcome and predictors of poor clinical response in extensively drug-resistant gram-negative urinary tract infection among children: A single-institution experience

被引:2
|
作者
Batalla-Bocaling, Carren Anne P. [1 ]
Tanseco, Patrick Vincent P. [2 ]
Chua, Michael E. [3 ]
机构
[1] Philippine Childrens Med Ctr, Sect Infect Dis, Quezon City, Philippines
[2] St Lukes Med Ctr, Inst Urol, Quezon City, Philippines
[3] Univ Toronto, Dept Surg, Div Urol, Hosp Sick Children, Toronto, ON, Canada
来源
关键词
ANTIBIOTIC-RESISTANCE; CAUSATIVE PATHOGENS; PRESSURE;
D O I
10.5489/cuaj.6475
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Extensively drug-resistant (XDR) is defined as isolates sensitive only to two or fewer antimicrobial categories. This paper aims to present the treatment outcome and identify factors associated with poor clinical response among children with XDR gram-negative urinary tract infection (UTI). Methods: This is a retrospective cohort conducted at a tertiary pediatric hospital from January 2014 to June 2017. All patients diagnosed with culture-proven XDR gram-negative UTI were identified and analyzed. Descriptive statistics were used to summarize demographic and clinical characteristics. Patients were categorized according to treatment outcomes: success vs. failure. Univariate analysis and multivariate logistic regression were used to assess statistical differences between the groups and determined patient variables that are predictive of poor response. Odds ratio (OR) and corresponding 95% confidence interval (CI) were generated. Results: A total of 29 (19.2%) XDR gram-negative pediatric UTI's were identified within the 42-month study period. No significant differences were noted in demographic characteristics between the groups. Treatment outcome of XDR gram-negative UTI patients showed that combination therapy with colistin had the highest success rate (40.9%), followed by non-colistin (36.4%) and combination therapy without colistin (22.7%). However, univariate analysis showed no significant difference among the different treatment groups (p=0.65). On multivariate logistic regression, receiving immunosuppressant and the presence of indwelling urinary catheters were independent predictors of poor clinical response among pediatric patients with XDR gram-negative UTI (OR 19.44, 95% CI 1.50-251.4, p=0.023 and OR 20.78, 95% CI 1.16-371.28, p=0.039; respectively). Conclusions: The treatment success rate of XDR gram-negative pediatric UTI ranged from 22.7-36.4%. This finding emphasizes the need to advocate antibiotic stewardship to prevent further increase in XDR UTIs. Indwelling urinary catheters and receipt of immunosuppressants are associated with poor clinical outcome.
引用
收藏
页码:E148 / E152
页数:5
相关论文
共 44 条
  • [1] Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
    Zhou, Li
    Feng, Shanglong
    Sun, Guangyu
    Tang, Baolin
    Zhu, Xiaoyu
    Song, Kaidi
    Zhang, Xuhan
    Lu, Huaiwei
    Liu, Huilan
    Sun, Zimin
    Zheng, Changcheng
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 481 - 491
  • [2] Treatment of Complicated Urinary Tract Infections With an Emphasis on Drug-Resistant Gram-Negative Uropathogens
    Matthew E. Levison
    Donald Kaye
    Current Infectious Disease Reports, 2013, 15 : 109 - 115
  • [3] Treatment of Complicated Urinary Tract Infections With an Emphasis on Drug-Resistant Gram-Negative Uropathogens
    Levison, Matthew E.
    Kaye, Donald
    CURRENT INFECTIOUS DISEASE REPORTS, 2013, 15 (02) : 109 - 115
  • [4] Predictors of mortality in patients with extensively drug-resistant gram-negative pneumonia receiving colistin therapy
    Wi, Y. M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S110 - S111
  • [5] Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
    Kliiman, K.
    Altraja, A.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) : 1085 - 1094
  • [6] Increasing Proportion of Extensively Drug-Resistant Gram-Negative Uropathogens among Renal Transplant Recipients in Northern India
    Bhuwania, Sameer
    Goel, Rajesh
    Bansal, Ravi
    Saxena, Sanjiv
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (04) : 416 - 417
  • [7] Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement
    Guan, X.
    He, L.
    Hu, B.
    Hu, J.
    Huang, X.
    Lai, G.
    Li, Y.
    Liu, Y.
    Ni, Y.
    Qiu, H.
    Shao, Z.
    Shi, Y.
    Wang, M.
    Wang, R.
    Wu, D.
    Xie, C.
    Xu, Y.
    Yang, F.
    Yu, K.
    Yu, Y.
    Zhang, J.
    Zhuo, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 : S15 - S25
  • [8] Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand
    Ngamprasertchai, Thundon
    Boonyasiri, Adhiratha
    Charoenpong, Lantharita
    Nimitvilai, Sireethorn
    Lorchirachoonkul, Narisorn
    Wattanamongkonsil, Luksame
    Thamlikitkul, Visanu
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 1219 - 1224
  • [9] Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study
    Yanik Yalcin, Tugba
    Azap, Ozlem
    Kose, Adem
    Bayindir, Yasar
    Saricaoglu, Elif Mukime
    Cinar, Gule
    Uygun Kizmaz, Yesim
    KurSun, Ebru
    Aliskan, Hikmet Eda
    Tezer Tekce, Yasemin
    Eren Kutsoylu, Oya Ozlem
    EgelI, Tufan
    Ari, Alpay
    Albayrak, Yurdagul
    Cabadak, Hatice
    Deniz, Secil
    Demir Onder, Kubra
    KizilateS, Filiz
    Ozger, Selcuk
    Guzel Tunccan, Ozlem
    Haberal, Mehmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1960 - 1968
  • [10] The nexus of extensively drug-resistant gram-negative bacteria and intensive care: Elucidating propagation patterns to fortify infection control measures
    Biswal, Debasish
    Mangla, Sandeep
    Khan, Sadia
    Chawla, Aayush
    Kumari, Pankhuri
    Pandey, Anubhav
    Sengupta, Sharmila
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2025, 53